IMVT
Immunovant Inc
Price:  
28.89 
USD
Volume:  
786,031.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMVT WACC - Weighted Average Cost of Capital

The WACC of Immunovant Inc (IMVT) is 10.9%.

The Cost of Equity of Immunovant Inc (IMVT) is 16.75%.
The Cost of Debt of Immunovant Inc (IMVT) is 5.00%.

Range Selected
Cost of equity 14.80% - 18.70% 16.75%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.9% - 11.8% 10.9%
WACC

IMVT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.38 2.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 14.80% 18.70%
Tax rate 0.10% 0.20%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 9.9% 11.8%
Selected WACC 10.9%